Peer reviewed paper ealth professionals wishing to expand the service that they offer to their patients must present their employers with a convincing cost-effective and evidence-based rationale for doing so. This article outlines the development of a business case to expand the intravenous therapy service in an English National Health Service trust.
What is a business case?
Business success or failure is determined by the level of input and decisions about how time and money is spent. Managers must present a clear and compelling business case if they want colleagues to listen to their ideas and if they want to make good decisions and improve performance in their organisation ( Cannon, 2005 ) . This theory may be applied to health care, for example as National Health Service (NHS) Trusts in England strive to meet government targets for infection control. Healthcare professionals are increasingly likely to be involved with the development of business cases. They need to recognise the key requirements for the success of business cases and understand the methods of evaluating alternative options contained within the case.
A business case is a document produced to support a proposal for the development of a new idea or a service improvement. This often involves increased fi nancial resources. Therefore a business case must demonstrate that the project is economically sound and fi nancially viable. It must demonstrate that it will improve patient care and outcomes, is supported by purchasers and will benefi t the Trust.
It is important to understand how cases should be formatted and presented for approval by an NHS Trust; they are often presented in a standardised template in accordance with localised policy. Prior to their presentation to the Trust's executive board they may require approval from the fi nancial team. The ability to produce a well written, succinct and persuasive business case is therefore essential for service expansion.
Questions that should be asked before writing a case
The business case itself does not translate an idea into action. It draws together a number of elements into a coherent whole. Before writing and presenting a case, key questions should be asked:
What service needs to be provided?
How can this service be provided effi ciently and effectively?
What additional fi nancial resource is needed?
(3) Does the service represent value for money? (4)
How will the project be managed? (5) What are the expected outcomes of the project? (6)
How will the outcomes be measured? (7) Justifi cation for the need for investment should cover one or more of the following: maintaining current services; service improvement; expansion of existing services; provision of new services; rationalisation to generate possible fi nancial savings.
Preparation of the case
Producing a business case should be treated as a project in its own right and should be co-ordinated by a single individual, whose background may vary depending on the project. Promoting effective change or building a business case involves a 'product champion' who can prepare locally based analysis of what needs to be done and how this may be achieved ( Lomas, 1993 ) . Effective leadership of the project is essential in order to achieve the identifi ed outcomes. The coordinating individual should form a group of key stakeholders to comment on and support the project at each stage of development. The individual should have a clear vision of the project, facilitate questioning from the group and effectively problem solve in order to create the business case ( Stanfi eld, 2000 ) . Effective planning and communication is vital at this point in order to form a comprehensive and evidence-based business case for presentation to the Trust.
The following staff are likely to be involved in the creation of a business case: colleagues within the department; key clinicians; managers; and possibly a representative from the fi nancial team. The Project Champion product champion will identify individuals' roles and responsibilities and develop the business case in four steps (see below), to timescales agreed within the group.
Step 1. The Strategic Context -Where are we now and where do we want to be?
Step 2. The Outline of the Case -Objectives and benefi ts and evaluation of options
Step 3. The Full Business Case -Develop the preferred option and seek approval
Step 4. Planning for the Evaluation of Outcomes.
An example of this process in an English NHS trust
Step 1. Where are we now and where do we want to be?
The author has been in post as Clinical Nurse Specialist for Intravenous (IV) Therapy since 1998 and has worked with an IV Practice Development Nurse for several years. In that time, roles have evolved and developed. The team's main role was to educate staff about all aspects of IV therapy, write and implement policies associated with IV therapy, place peripheral cannulae, and audit services within the Trust. In 2001, the author introduced a nurse-led peripherally inserted central catheter (PICC) insertion service into the trust. Initially the PICC service was provided for a limited number of specialties within the trust: oncology patients receiving chemotherapy, patients with digestive diseases receiving total parenteral nutrition (TPN) and respiratory patients requiring long-term antibiotics. Four other nurses were identifi ed and trained to place PICCs within these specialties. They supported the IV nurses as they were able to insert PICCs when their workload allowed them to.
The service expanded naturally as more specialties became aware of its existence. In 2002, the IV Team inserted 95 PICCs. The demand for the service continued to increase and in 2006 the IV Team inserted 245 PICCs. The IV Team became unable to meet demands for PICC insertion as these demands continued to increase while the team endeavoured to maintain the existing educational programme.
Audit showed that there was a high rate of phlebitis associated with peripheral cannulae in the trust. The IV nurses were unable to address this because their major role had changed from educating and advising to providing the PICC insertion service.
The use of medical devices is one of the two strongest link factors associated with healthcare associated infections (HCAIs), the other being the degree of a patient's underlying illness ( Parliamentary Offi ce for Science and Technology (POST), 2005 ). Bloodstream infection makes up 6 % of all HCAIs in the NHS, and 42.3 % of these are a result of the use of intravenous catheters ( Department of Health (DH), 2007 ) . In the United States the Institute for Healthcare Improvement (IHI, 2005) has estimated the costs of these infections at $29,000 dollars per patient. In England, the National Audit Offi ce (2000) estimated average costs of £6209 for each patient with a healthcare-associated infection. In the local Trust, there were 207 meticillin resistant Staphylococcus aureus (MRSA) bacteraemias recorded in 2004/05; 48 of these were associated with intravenous lines.
There is evidence that if cannulae are inserted by inexperienced staff, the risk of trauma and infection increases ( Collignon, 1994 ) . Guidelines from the United States of America stated that 'specialised IV Teams have shown unequivocal effectiveness in reducing the incidence of catheter related infections and associated complications and costs' ( Centers for Disease Control (CDC), 2002 ; Palefski and Stoddard, 2001 ) . The English Department of Health publications Winning Ways (DH, 2003) and Saving Lives ( DH, 2005 ) asked Trusts to formulate an action plan for the reduction of intravenous catheter infection.
As part of the action plan, the author wrote and presented a business case. The aim of the business case was to increase the size of the IV nursing team and also to create a separate cannulation team in the Trust.
The author carried out a situational analysis using a PEST (politico-legal, economic, social and technical factors) and SWOT (strengths, weaknesses, opportunities and threats) analysis at all levels to look at the feasibility of expanding the IV team in the Trust. These analyses are shown in Table 1 and Table 2 . As well as the PEST and SWOT analyses, the author carried out an audit which revealed that in 2004/05 the Trust had had the 48 infections associated with vascular access devices mentioned above.
Table 1. PEST analysis
Politico-legal Role change and service change is occurring as professionals expand existing services. Care in the 21st century is based on partnerships, depending on fl exible teams providing services to meet patients' needs ( Lockhart, 2005 ) . The Royal College of Nursing (RCN) supports initiatives involved in changing traditional ways of working and professional boundaries ( RCN, 2004 ) and also supports the development of nursing roles ( RCN, 2005 ) ; introducing a cannulation team would reduce the amount of procedures undertaken out of hours by junior doctors. ( Scott, 1999 ) . Economic
The cost of a healthcare associated infection (HCAI) is estimated as £6209 per case ( National Audit Offi ce, 2000 ). On average, patients stay in hospital for an extra 7.4 days ( Hayley et al, 1980 ) . This may have an impact on the Trust's ability to achieve set targets for waiting times for surgery or admission from the Accident and Emergency Department. Fitsimmons et al (1997) found that training nurses to perform insertion of central lines improved the quality of the service and gave junior doctors more opportunity to get on with other work. Caine (2002) supported this view and stated that nurses were more cost effective and also missed fewer clinically signifi cant events than junior doctors. Nurse-led care was equally safe and effi cient and had better patient satisfaction and outcomes. On a local level, patients were being transferred to a local private hospital for insertion of cuffed tunnelled central catheters at a cost of £1800 per patient. The business case set out to repatriate this service to the Trust. Potentially other savings would be identifi ed as an expanded IV team could examine IV consumables in the Trust and standardise products. Social
Initiatives in the NHS in England are aimed at redefi ning the traditional structure of the organisation. Making a Difference considered ways to strengthen nursing and to relate to the changing needs of patients. ( DH, 1999 ) Traditional medical roles are being increasingly delegated to nurses. Extending nurses' roles should be done at the nurses' discretion ( Tingle, 1997 ) and the identifi ed nurses must receive additional training and achieve competence-based assessments. Technical
Advances in vascular access techniques require skilled staff to perform them safely. For example, national guidelines recommend the use of ultrasound for obtaining central venous access in patients (NICE, 2002) . As junior doctors move across specialties, the level of skills in practice may dip ( Brunelle, 2003 ) . The presence of a skilled IV Team in the Trust would prevent this impacting adversely on patients.
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Step 2. The outline of the case The group of staff approached to support the project consisted of the lead Consultant for microbiology, the Chief Nurse, the antibiotic pharmacist and a member of the Trust's fi nancial team. The author requested support in principle and presented published evidence, local statistics and audit results with a proposal to expand the IV team to the Trust's Infection Control, Patient Safety and Clinical Governance Committees in order to gain the support of these key groups. This outlined the potential benefi ts to patients, staff and the Trust (see Table 3 ).
The business case was outlined as a 'spend to save' project to the trust's executive board. Three options were presented in the business case, along with an executive summary.
The executive summary outlined the current IV service, other resources that could be used, the vascular access devices (VADs) that 
Strengths
Advanced Practitioner roles are supported by the Nursing and Midwifery Council (NMC, 2007) . High standards of performance would contribute to atraumatic cannulation and reduce associated complications. ( Jackson, 2007 ) . There would be reduction in risk associated with vascular access devices (VADs). IV teams have been shown to reduce HCAIs ( Maki, 1987 ) . Staff are more likely to comply with policy if there is a visible IV team in post ( Mendez, 1987 ) . Compliance with policy and reduction in infection rates reduces costs signifi cantly. Costs and risks can be further reduced by local rationalisation and standardisation of equipment. Nursing staff expect junior doctors to cannulate patients with diffi cult veins; they are delegating cannulation to the trusts' most junior staff. Having a cannulation team would improve the patients' experience, reduce complication rates and also reduce stress and workload for junior medical staff ( Soiffer et al, 1998 ) . Carlquist (1981) commented that there is a reduction in complaints from patients and their satisfaction increases if they are seen by an expert.
Weaknesses
Most of the data and literature was from the USA and there were few nurse-led IV teams in the United Kingdom (UK) ( Jackson, 2003 ) . Performing tasks in isolation does not appear to offer holistic care to patients and this is a medical model of care. There could be a danger of team members losing nursing status and becoming 'mini doctors' ( Schaeffer, 1998 ) . There could be professional tensions and deskilling of medical staff ( Bowler and Mallick, 2005 ) , and there could be role confl ict arising if the view of the role holder differs from that of the multidisciplinary team.
Role confl ict could result if the IV team were seen as elitist.
Opportunities IV therapy would be planned, minimising risks for patients ( Weinstein, 2000 ) . Stress levels for both patients and staff would reduce as there would be an expert to call to perform tasks. The members of the existing IV team would have a better sense of job satisfaction ( RCN, 2005 ) . Threats
Legislation may change, as could targets for the NHS. There could be opposition from medical staff and blurring of professional boundaries ( Upton and Brooks, 2000 ) . Managerial staff cautious of change due to fi nancial constraints and lack of resources may also present barriers ( Davies, 2000 ) . Peer reviewed paper were used in the Trust (along with the costs) and the lack of standardisation of IV consumables. The drivers for change were the incidence of HCAIs associated with VADs, the high phlebitis rates associated with peripheral cannulae, poor adherence of staff to IV policies, the target for English NHS Trusts to reduce MRSA bacteraemias by 50 % from a 2003/04 baseline, lack of provision of adequate education in IV therapy and the level of other risks that are associated with IV therapy such as medication errors.
Step 3. The business case A proposed service model was developed and non-fi nancial benefi ts of the preferred option were stated. The options and costs presented are shown in Table 4 , with the aim to achieve support for Option 3.
The benefi ts rationalisation stated clearly how the project would be achieved, who would achieve it, timescales for all aspects of the project and how the outcomes would be measured and presented.
For example, the business case stated that the Clinical Nurse Specialist would meet with the fi nancial team on a weekly basis to ensure that the cost savings were met.
Step 4. Measuring the outcomes The business case was developed throughout 2006 and presented to the Executive Board in June 2007. Option 3 was approved. The trust invested £170,000 with a promised return of £356,000, along with all the non-fi nancial benefi ts that had been outlined in the business case.
The fully expanded IV team was put into post in November 2007 and the service has been audited continuously since that time. Results and outcomes are presented to the Trust in an annual report. Staff costs are based on the salary at the mid-point of the relevant NHS 'Agenda for Change' pay band at the time of the proposal and an additional 15% 'on costs'.
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Conclusion
Writing and implementing a business case can be a lengthy process. Managers must present a clear and compelling business case if they want colleagues to listen to their ideas and if they want to make good decisions and improve performance in their organisation. A well researched and presented business case enables NHS Trusts to accept that there may be different and possibly more effective methods of care and services to those that they are currently employing.
The expansion of the IV therapy team in the Trust has been a very successful and exciting project that has made a huge impact on the outcomes of patients, staff and the trust.
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